TEGOPRUBART FOR THE TREATMENT OF PATIENTS WITH IGA NEPHROPATHY: A SNAPSHOT OF EMERGING DATA FROM AB ONGOING TRIAL
Back
Abstract Number
WCN23-0479
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Inflammation, Fibrosis, Matrix Biology and Oxidative Stress
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
TEGOPRUBART FOR THE TREATMENT OF PATIENTS WITH IGA NEPHROPATHY: A SNAPSHOT OF EMERGING DATA FROM AB ONGOING TRIAL
Co-authors
Barratt, J.(1);Liew, A.(2);Rizk, D.(3);Willcocks, L.(4);Lafayette, R.(5);Wong, M.G.(6);Tesar, V.(7);Bornstein, J.(8)*;Mak, C.(9);Reich, H.(10);Tang, S.(11);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)University Of Leicester, Renal Medicine, Leicester, United Kingdom;(2)Mount Elizabeth Novena Hospital, Renal Medicine, Singapore, Singapore;(3)University Of Alabama Birmingham, Nephrology, Birmingham, United States;(4)Addenbrookes, Nephrology, Cambridge, United Kingdom;(5)Stanford, Nephrology, Palo Alto, United States;(6)University Of Sydney, Nephrology, Sydney, Australia;(7)Charles University, Nephrology, Prague, Czech Republic;(8)Eledon Pharmaceuticals, Research And Development, Burlington, United States;(9)Eledon Pharmaceuticals, Biometrics, Burlington, United States;(10)University Of Toronto, Nephrology, Toronto, Canada;(11)University Of Hong Kong, Nephrology, Hong Kong, Hong Kong- China;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/b910c3472d4c2273e6be9fc07fed8bab.pdf
Audio File
if any